PCOS Is Now PMOS, but a Yale Expert Says the New Name Alone Won’t Change Care

In May 2026, the hormonal condition long known as polycystic ovary syndrome (PCOS) got a new name. It is now called polyendocrine metabolic ovarian syndrome, or PMOS, a name chosen by a global coalition of patients, clinicians and medical organizations to better capture the condition’s broad hormonal and metabolic effects. The condition affects about one in eight women worldwide.

For Lubna Pal, M.B.B.S., professor in the Division of Reproductive Endocrinology and Infertility at Yale School of Medicine, the change is a welcome step, but only a first one.

How tiny follicles became “cysts”

When the condition was first described in 1935, it was identified in women with long-standing irregular periods, excess hair growth and acne and whose ovaries looked enlarged with a thick outer coating during surgery.

Pal explained that what appears as “cysts” on ultrasound are usually tiny follicles, the structures that hold eggs. Many patients hear “cyst” and assume disease. Some even confuse painful, ruptured ovarian cysts with PCOS, but a ruptured cyst is not a polycystic ovary, she said.

A diagnosis that narrowed care

Pal recalled a time when internists, endocrinologists and gynecologists all cared for these patients. As ultrasound findings became part of the diagnostic criteria, the condition increasingly came to be seen as a gynecological problem. Patients were sent to fertility specialists when they weren’t seeking fertility care, and parents of teenagers began worrying about future pregnancy.

Meanwhile, risks such as insulin resistance, prediabetes, heart disease, mental health concerns, and precancer or cancer of the uterine lining, which can develop when periods are absent for long stretches, got less attention.

Irregular periods as a warning light

“Irregularity of cycles is a vital sign. It’s like a pulse. It’s like blood pressure,” Pal said.

The reproductive system is often the first to be thrown off by stress, poor sleep or weight changes, she explained. In her practice, many patients can trace irregular cycles to a life transition, such as starting college or a new job. She estimates that almost half of the women she sees could drop the label if those underlying factors were addressed.

She also offered reassurance. Many women with this diagnosis have plenty of eggs, and ovulation problems are often correctable. “Fertility is a team sport,” she added.

A new name, the same criteria

Patients and the public were surveyed and patient representatives took part in the renaming discussions, Pal said, though she was not involved herself. She believes the ovary stayed in the name to preserve continuity with decades of research, but she would have preferred otherwise. “We should have dropped the ovary,” she said, noting that ovarian dysfunction stems from a cascade of signals elsewhere in the body.

Importantly, the diagnostic criteria haven’t changed. “They should not expect anything to change,” Pal said of patients, stressing that women need to be active participants in their care.

Questions to bring to your care team

Pal encourages women to ask why they meet the criteria, what their blood sugar and cholesterol look like, how family history affects their risk, and what their short- and long-term health goals are.

“We treat the person; we don’t treat the label,” she said.